Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy.

Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy. J Clin Rheumatol. 2014 Dec; 20(8):427-32.

View in: PubMed

subject areas

Aged
Chronic Disease
Clinical Trials, Phase III as Topic
Cluster Analysis
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Resistance
Drug-Related Side Effects and Adverse Reactions
Female
Follow-Up Studies
Gout
Gout Suppressants
Humans
Infusions, Intravenous
Male
Middle Aged
Polyethylene Glycols
Randomized Controlled Trials as Topic
Risk Assessment
Severity of Illness Index
Time Factors
Treatment Outcome
Urate Oxidase
Uric Acid

authors with profiles

Michael A. Becker